Published in Cancer Weekly, March 11th, 2003
According to a study from South Korea, "Multidrug resistance has been a major problem in cancer chemotherapy. In this study, in vitro and in vivo modulations of MDR by ginsenoside Rg3, a red ginseng saponin, were investigated. In flow cytometric analysis using rhodamine 123 as an artificial substrate, Rg3 promoted accumulation of rhodamine 123 in drug resistant KBV20C cells in a dose dependent manner, but it had no effect on parental KB cells.
"Additionally, Rg3 inhibited [H3]vinblastine efflux and reversed MDR to doxorubicin, COL, VCR, and VP-16 in KBV20C...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.